Activated TGFβ Signaling in the Heart After Myocardial Infarction

  • Jianming Hao
  • Tracy Scammell-La Fleur
  • Ian M. C. Dixon
Part of the Progress in Experimental Cardiology book series (PREC, volume 3)


We have previously shown that myofibroblasts of the healed 8 week infarct scar overexpress transduction proteins that may be linked to elevated deposition of extracellular matrix components in this tissue. Other work suggests that TGFβ1, may be involved in cardiac fibrosis and myocyte hypertrophy. The significance of the altered TGFβ signaling in heart failure in the chronic phase of post-myocardial infarction (MI), particularly in the ongoing remodeling of the infarct scar, remains unexplored. Patterns of cardiac TGFβ1 and Smad 2, 3, and 4 protein expression were investigated 8 weeks after MI and were compared to relative collagen deposition in border tissues (containing remnant myocytes) and the infarct scar (nonmyocytes dominated by myofibroblasts). Both TGFβ1 mRNA abundance (Northern analysis) and protein levels (ELISA) were significantly increased in the infarct scar versus control values, and this trend was positively correlated to increased collagen type I expression in this tissues. Cardiac Smad 2, 3, and 4 proteins were significantly increased in border and scar tissues versus control values. Immunofluorescent studies indicated that Smad proteins were proximally localized to cellular nuclei in the infarct scar. TβRI (53 kDa) protein expression was significantly reduced in the scar, while the 75kDa and 110kDa isoforms of TβRII were unchanged and significantly increased respectively, in the infarct scar. These results indicate that TGFβ/Smad signaling may be involved in the remodeling of the infarct scar after the completion of wound healing per se, via ongoing stimulation of matrix deposition.


Scar Tissue Smad Protein Hypertrophy Heart Infarct Scar Border Tissue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pfeffer JM, Fischer TA, Pfeffer MA. 1995. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Arum Rev Physiol 57:805–826.CrossRefGoogle Scholar
  2. 2.
    Pfeffer MA, Braunwale E. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161–1172.PubMedCrossRefGoogle Scholar
  3. 3.
    Weber KT, Sun Y, Katwa LC, 1996. Wound healing following myocardial infarction. Clin Cardiol 19:447–455.PubMedCrossRefGoogle Scholar
  4. 4.
    Border WA, Noble NA. 1994. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292.PubMedCrossRefGoogle Scholar
  5. 5.
    Brand T, Schneider MD. 1995. The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol. 27:5–18.PubMedCrossRefGoogle Scholar
  6. 6.
    Eghbali M, Sigel A. 1995. Role of transforming growth factor beta-1 in the remodeling of collagen matrix in the heart. In Heart Hypertrophy and Failure. Ed. NS Dhalla, GN Pierce, V Panagia, and RE Beamish, 287–297. Boston: Kluwer Academic Publishers.CrossRefGoogle Scholar
  7. 7.
    Thompson NL, Bazoberry F, Speir EH, Casscells W, Ferrans VJ, Flanders KC, Kondaiah P, Geiser AG, Sporn MB. 1988. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1:91–99.PubMedCrossRefGoogle Scholar
  8. 8.
    Macias Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. 1996. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215–1224.CrossRefGoogle Scholar
  9. 9.
    Massague J, Hata A, Liu F. 1997. Tgf-beta signalling through the Smad pathway. Trends Cell Biol 7:187–192.CrossRefGoogle Scholar
  10. 10.
    Engelmann GL, Boehm KD, Birchenall Roberts MC, Ruscetti FW. 1992. Transforming growth factor-beta 1 in heart development. Mech Dev 38:85–97.PubMedCrossRefGoogle Scholar
  11. 11.
    Eghbali M. 1989. Cellular origin and distribution of transforming growth factor-beta in the normal rat myocardium. Cell Tissue Res 256:553–558.PubMedCrossRefGoogle Scholar
  12. 12.
    Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ. 1995. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27:2347–2357.PubMedCrossRefGoogle Scholar
  13. 13.
    Flanders KC, Winokur TS, Holder MG, Sporn MS. 1993. Hyperthermia induces expression of transforming growth factor-betas in rat cardiac cells in vitro and in vivo. J Clin Invest 92:404–410.PubMedCrossRefGoogle Scholar
  14. 14.
    Takahashi N, Calderone A, Izzo NJ Jr, Maki TM, Marsh JD, Colucci WS. 1994. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J Clin Invest 94:1470–1476.PubMedCrossRefGoogle Scholar
  15. 15.
    Engelmann GL, Grutkoski PS. 1994. Coordinate TGF-beta receptor gene expression during rat heart development. Cell Mol Biol Res 40:93–104.PubMedGoogle Scholar
  16. 16.
    Massague J. 1990. The transforming growth factor-beta family. Annu Rev Cell Biol 6:597–641.PubMedCrossRefGoogle Scholar
  17. 17.
    Heimer R, Bashey RI, Kyle J, Jimenez SA. 1995. TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J Mol Cell Cardiol 27:2191–2198.PubMedCrossRefGoogle Scholar
  18. 18.
    Chua CC, Chua BH, Zhao ZY, Krebs C, Diglio C, Perrin E. 1991. Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 26:271–281.PubMedCrossRefGoogle Scholar
  19. 19.
    Villarreal FJ, Lee AA, Dillmann WH, Giordano FJ. 1996. Adenovirus-mediated overexpression of human transforming growth factor-beta 1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J Mol Cell Cardiol 28:735–742.PubMedCrossRefGoogle Scholar
  20. 20.
    Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B. 1991. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 69:483–490.PubMedCrossRefGoogle Scholar
  21. 21.
    Vracko R, Thorning D. 1991. Contractile cells in rat myocardial scar tissue. Lab Invest 65:214–227.PubMedGoogle Scholar
  22. 22.
    Holmes JW, Nunez JA, Covell JW. 1997. Functional implications of myocardial scar structure. Am J Physiol 272:H2123–H2130.PubMedGoogle Scholar
  23. 23.
    Dixon IMC, Lee SL, Dhalla NS. 1990. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 66:782–788.PubMedCrossRefGoogle Scholar
  24. 24.
    Ju H, Zhao S, Tappia PS, Panagia V, Dixon IMC. 1998. Expression of Gqalpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation 97:892–899.PubMedCrossRefGoogle Scholar
  25. 25.
    Dixon IMC, Hata T, Dhalla NS. 1992. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol 262:H1387–H1394.PubMedGoogle Scholar
  26. 26.
    Ju H, Zhao S, Davinder SJ, Dixon IM, 1997. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res 35:223–232.PubMedCrossRefGoogle Scholar
  27. 27.
    Chiariello M, Ambrosio G, Cappelli Bigazzi M, Perrone Filardi F, Brigante F, Sifola C. 1986. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol 18:283–290.PubMedCrossRefGoogle Scholar
  28. 28.
    Junaid A, Rosenberg ME, Hostetter TH. 1997. Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney [published erratum appears in J Am Soc Nephrol 1998;9(1):154]. J Am Soc Nephrol 8:1732–1738.PubMedGoogle Scholar
  29. 29.
    Peterson D, Ju H, Panagia M, Chapman D, Dixon IMC. In press. Expression of Gia2 and Gsa in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc Res.Google Scholar
  30. 30.
    Smith PK, Krohn RI, Hermanson GT, Mania AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85.PubMedCrossRefGoogle Scholar
  31. 31.
    Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159.PubMedCrossRefGoogle Scholar
  32. 32.
    Ju H, Scammel La Fleur T, Dixon IMC. 1996. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol 28:1119–1128.PubMedCrossRefGoogle Scholar
  33. 33.
    Hall FL, Benya PD, Padilla SR, Carbonaro Hall D, Williams R, Buckley S, Warburton D. 1996. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies, Biochem J 316:303–310.PubMedGoogle Scholar
  34. 34.
    Pelouch V, Dixon IM, Sethi R, Dhalla NS. 1993. Alteration of collagenous protein profile in congestive heart failure secondary to myocardial infarction. Mol Cell Biochem 129:121–131.PubMedCrossRefGoogle Scholar
  35. 35.
    Roberts AB, Sporn MB. 1990. The transforming growth factor-betas. In Peptide Growth Factors and Their Receptors I. Ed. MB Sporn, AB Roberts, 420–472. New York: Springer-Verlag.Google Scholar
  36. 36.
    Li JM, Brooks G. 1997. Differential protein expression and subcellular distribution of TGF beta1, beta2 and beta3 in cardiomyocytes during pressure overload-induced hypertrophy. J Mol Cell Cardiol 29:2213–2224.PubMedCrossRefGoogle Scholar
  37. 37.
    Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. 1994. Mechanim of activation of the TGF-beta receptor. Nature 370:341–347.PubMedCrossRefGoogle Scholar
  38. 38.
    Zhang Y, Feng X, We R, Derynck R. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383:168–172.PubMedCrossRefGoogle Scholar
  39. 39.
    Lagna G, Hata A, Hemmati Brivanlou A, Massague J. 1996. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383:832–836.PubMedCrossRefGoogle Scholar
  40. 40.
    Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85–89.PubMedCrossRefGoogle Scholar
  41. 41.
    Liu F, Pouponnot C, Massague J. 1997. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev 11:3157–3167.PubMedCrossRefGoogle Scholar
  42. 42.
    Weber KT. 1989. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13:1637–1652.PubMedCrossRefGoogle Scholar
  43. 43.
    Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. 1995. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol 25:567–573.PubMedCrossRefGoogle Scholar
  44. 44.
    Fishbein MC, Maclean D, Maroko PR. 1978. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57–70.PubMedGoogle Scholar
  45. 45.
    Willems IE, Havenith MG, De Mey JG, Daemen MJ. 1994. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145:868–875.PubMedGoogle Scholar
  46. 46.
    Cleutjens JP, Verluyten MJ, Smits JF, Daemen MJ. 1995. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147:325–338.PubMedGoogle Scholar
  47. 47.
    Mucsi I, Goldberg HJ. 1997. Dominant-negative SMAD-3 interferes with transcriptional activation by multiple agonists. Biochem Biophys Res Commun 232:517–521.PubMedCrossRefGoogle Scholar
  48. 48.
    Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Ladish HE 1997. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Nad Acad Sci USA 94:10669–10674.CrossRefGoogle Scholar
  49. 49.
    Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. 1993. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 25:1369–1380.PubMedCrossRefGoogle Scholar
  50. 50.
    Lefroy DC, Wharton J, Crake T, Knock GA, Rutherford RA, Suzuki T, Morgan K, Polak JM, Poole-Wilson PA. 1996. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 28:429–440.PubMedCrossRefGoogle Scholar
  51. 51.
    Sun Y, Weber KT. 1996. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res 31:518–525.PubMedGoogle Scholar
  52. 52.
    Brilla CG, Zhou G, Matsubara L, Weber KT. 1994. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26:809–820.PubMedCrossRefGoogle Scholar
  53. 53.
    Crabos M, Roth M, Hahn AW, Erne P. 1994. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest 93:2372–2378.PubMedCrossRefGoogle Scholar
  54. 54.
    Sadoshima J, Izumo S. 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73:413–423.PubMedCrossRefGoogle Scholar
  55. 55.
    Miyazono K. 1997. TGF-beta receptors and signal transduction. Int J Hematol 65:97–104.PubMedCrossRefGoogle Scholar
  56. 56a.
    Massague J. 1998. TGF-beta signal transduction. Arum Rev Biochem 67:753–91:753–791.CrossRefGoogle Scholar
  57. 56b.
    Massague J. 1998. TGF-beta signal transduction. Arum Rev Biochem 67:753–791CrossRefGoogle Scholar
  58. 57.
    McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, Bush HLJ. 1995. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-betal. J Clin Invest 96:2667–2675.PubMedCrossRefGoogle Scholar
  59. 58.
    Centrella M, Ji C, Casinghino S, McCarthy TL. 1996. Rapid flux in transforming growth factor-beta receptors on bone cells. J Biol Chem 271:18616–18622.PubMedCrossRefGoogle Scholar
  60. 59.
    Ward MR, Agrotis A, Jennings G, Bobik A. 1998. Vascular types I and II transforming growth factorbeta receptor expression: differential dependency on tyrosine kinases during induction by TGF-beta. FEBS Lett 422:197–200.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Jianming Hao
    • 1
    • 2
  • Tracy Scammell-La Fleur
    • 1
    • 2
  • Ian M. C. Dixon
    • 1
    • 2
  1. 1.Laboratory of Molecular Cardiology, Institute of Cardiovascular SciencesSt. Boniface General Hospital Research CentreWinnipegCanada
  2. 2.Faculty of MedicineUniversity of ManitobaWinnipegCanada

Personalised recommendations